Minnesota Legislature
SF 2899
2nd Engrossment - 84th Legislature (2005 - 2006) Posted on 12/15/2009 12:00am
Current Version - 2nd Engrossment
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 2.33 2.34 2.35 2.36 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 3.31 3.32 3.33 3.34 3.35 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 4.24 4.25 4.26 4.27
4.28 4.29 4.30 4.31 4.32 4.33
4.34 5.1 5.2
5.3
A bill for an act
relating to health; establishing a controlled substances reporting program;
providing for disciplinary action; proposing coding for new law in Minnesota
Statutes, chapter 152.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
Section 1.
new text begin
[152.126] ALL SCHEDULES PRESCRIPTION ELECTRONIC
REPORTING PROGRAM.
new text end
new text begin Subdivision 1. new text end
new text begin Definitions. new text end
new text begin
For purposes of this section, the terms defined in this
subdivision have the meanings given.
new text end
new text begin
(a) "Board" means the Minnesota State Board of Pharmacy established under
chapter 151.
new text end
new text begin
(b) "Controlled substances" means those substances listed in section 152.02,
subdivisions 3 to 6, and those substances defined by the board pursuant to section 152.02,
subdivisions 7, 8, and 12.
new text end
new text begin
(c) "Dispense" or "dispensing" has the meaning given in section 151.01, subdivision
30.
new text end
new text begin
(d) "Dispenser" means a person authorized by law to dispense, pursuant to a valid
prescription, a controlled substance. A dispenser does not include a licensed hospital
pharmacy that distributes controlled substances for inpatient hospital care.
new text end
new text begin
(e) "Prescriber" means a licensed health care professional who is authorized to
prescribe a controlled substance under section 152.12, subdivision 1.
new text end
new text begin
(f) "Prescription" has the meaning given in section 151.01, subdivision 16.
new text end
new text begin Subd. 2. new text end
new text begin Establishment of a prescription electronic reporting program. new text end
new text begin
(a) The
board shall establish by January 1, 2008, an electronic system for reporting the information
required under subdivision 4 for all controlled substances dispensed within the state.
new text end
new text begin
(b) The board may contract with a vendor for the purpose of obtaining technical
assistance in the design, implementation, and maintenance of the electronic reporting
system. The vendor's role shall be limited to providing technical support to the board
concerning the software, databases, and computer systems required to interface with the
existing systems currently used by pharmacies to dispense prescriptions and transmit
prescription data to other third parties.
new text end
new text begin Subd. 3. new text end
new text begin Prescription Electronic Reporting Advisory Committee. new text end
new text begin
(a) The board
may convene an advisory committee. If the board convenes a committee, the committee
must include at least one representative of:
new text end
new text begin
(1) the Department of Health;
new text end
new text begin
(2) the Department of Human Services;
new text end
new text begin
(3) each health-related licensing board that licenses prescribers;
new text end
new text begin
(4) a professional medical association, which may include an association of pain
management and chemical dependency specialists;
new text end
new text begin
(5) a professional pharmacy association; and
new text end
new text begin
(6) a consumer or patient rights organization.
new text end
new text begin
(b) The advisory committee shall advise the board on the development and operation
of the electronic reporting system, including, but not limited to:
new text end
new text begin
(1) technical standards for electronic prescription drug reporting;
new text end
new text begin
(2) proper analysis and interpretation of prescription monitoring data; and
new text end
new text begin
(3) an evaluation process for the program.
new text end
new text begin Subd. 4. new text end
new text begin Reporting requirements. new text end
new text begin
(a) Each dispenser must submit the following
data to the board or its designated vendor:
new text end
new text begin
(1) name of the prescriber;
new text end
new text begin
(2) national provider identifier of the prescriber;
new text end
new text begin
(3) name of the dispenser;
new text end
new text begin
(4) national provider identifier of the dispenser;
new text end
new text begin
(5) name of the patient for whom the prescription was written;
new text end
new text begin
(6) date of birth of the patient for whom the prescription was written;
new text end
new text begin
(7) date the prescription was written;
new text end
new text begin
(8) date the prescription was filled;
new text end
new text begin
(9) name and strength of the controlled substance;
new text end
new text begin
(10) quantity of controlled substance prescribed; and
new text end
new text begin
(11) quantity of controlled substance dispensed.
new text end
new text begin
(b) The dispenser must submit the required information by a procedure and in a
format established by the board.
new text end
new text begin
(c) A dispenser is not required to submit this data for those controlled substance
prescriptions dispensed for individuals residing in licensed skilled nursing or intermediate
care facilities.
new text end
new text begin Subd. 5. new text end
new text begin Use of data by board. new text end
new text begin
The board shall develop and maintain a database of
the data reported under subdivision 4 and shall use the database for the identification of:
new text end
new text begin
(1) individuals receiving prescriptions for controlled substances from prescribers
who subsequently obtain controlled substances from dispensers in quantities or with a
frequency inconsistent with generally recognized standards of dosage for those controlled
substances; and
new text end
new text begin
(2) individuals presenting forged or otherwise false or altered prescriptions for
controlled substances to dispensers.
new text end
new text begin Subd. 6. new text end
new text begin Access to prescription electronic reporting program data. new text end
new text begin
(a) Except as
indicated in this subdivision, the data submitted to the board under subdivision 4 is private
data on individuals as defined in section 13.02, subdivision 12.
new text end
new text begin
(b) The board may provide data submitted under subdivision 4 for public research,
policy or education purposes, to the extent that any information that is likely to reveal the
identity of the patient or other person who is the subject of the data has been removed.
new text end
new text begin
(c) The following persons may access the data submitted under subdivision 4 in the
same or similar manner, and for the same or similar purposes, as those persons who are
authorized to access similar private data on individuals under federal and state law:
new text end
new text begin
(1) a prescriber, to the extent the information relates specifically to a current patient
of the prescriber, to whom the practitioner is prescribing or considering prescribing any
controlled substance;
new text end
new text begin
(2) a dispenser to the extent the information relates specifically to a current patient to
whom that dispenser is dispensing or considering dispensing any controlled substance;
new text end
new text begin
(3) an individual who is the recipient of a controlled substance prescription for
which data was submitted under subdivision 4;
new text end
new text begin
(4) personnel of the board specifically assigned to conduct investigations related to
controlled substances laws under the jurisdiction of the board;
new text end
new text begin
(5) personnel of the board engaged in the collection of controlled substance
prescription information as part of the assigned duties and responsibilities of their
employment;
new text end
new text begin
(6) authorized personnel of a vendor under contract with the board who are engaged
in the design, implementation, and maintenance of the electronic reporting system as part
of the assigned duties and responsibilities of their employment, provided that access to data
is limited to the minimum amount necessary to test and maintain the system databases;
new text end
new text begin
(7) a designated representative of a health-related licensing board responsible for the
licensure, regulation, or discipline of prescribers or dispensers provided that the requested
data relates to a bona fide investigation of a specific licensee;
new text end
new text begin
(8) federal, state, and local law enforcement authorities engaged in a bona fide
investigation of a specific person; and
new text end
new text begin
(9) personnel of the medical assistance program assigned to use the data collected
under this section to identify recipients whose usage of controlled substances may warrant
restriction to a single primary care physician, a single outpatient pharmacy, or a single
hospital.
new text end
new text begin
(d) The board shall not release data submitted under this section unless it is provided
with evidence, satisfactory to the board, that the person requesting the information is
entitled to receive the data.
new text end
new text begin Subd. 7. new text end
new text begin Disciplinary action. new text end
new text begin
(a) A dispenser who knowingly fails to submit data to
the board as required under this section is subject to disciplinary action by the appropriate
health-related licensing board.
new text end
new text begin
(b) A prescriber or dispenser authorized to access the data who knowingly discloses
the data in violation of state or federal laws relating to the privacy of healthcare data shall
be subject to disciplinary action by the appropriate health-related licensing board.
new text end
new text begin Subd. 8. new text end
new text begin Evaluation and reporting. new text end
new text begin
(a) The board shall evaluate the prescription
electronic reporting program to determine if the program is cost-effective. The board may
contract with a vendor to design and conduct the evaluation.
new text end
new text begin
(b) The board shall submit the evaluation of the program to the legislature by
January 15, 2009.
new text end
new text begin EFFECTIVE DATE. new text end
new text begin
This section is effective July 1, 2006, or upon receiving
sufficient nonstate funds to implement the prescription electronic reporting program,
whichever is later. In the event that nonstate funds are not secured by the Board of
Pharmacy to adequately fund the implementation of the prescription electronic reporting
program, the board is not required to implement section 1, without a subsequent
appropriation from the legislature.
new text end
Sec. 2. new text begin FEDERAL GRANTS.
new text end
new text begin
The Board of Pharmacy shall apply for any applicable federal grants or other nonstate
funds to establish and fully implement the prescription electronic reporting program.
new text end
new text begin EFFECTIVE DATE. new text end
new text begin
This section is effective the day following final enactment.
new text end